BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 28767734)

  • 21. Effect of diabetes duration on the relationship between glycaemic control and risk of death in older adults with type 2 diabetes.
    Ghouse J; Isaksen JL; Skov MW; Lind B; Svendsen JH; Kanters JK; Olesen MS; Holst AG; Nielsen JB
    Diabetes Obes Metab; 2020 Feb; 22(2):231-242. PubMed ID: 31596048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validity of random blood glucose as a predictor of the quality of glycaemic control by glycated haemoglobin in out-patient diabetic patients at Kenyatta National Hospital.
    Otieno FC; Ng'ang'a L; Kariuki M
    East Afr Med J; 2002 Sep; 79(9):491-5. PubMed ID: 12625691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of 6 months' flash glucose monitoring in adolescents and young adults with type 1 diabetes and suboptimal glycaemic control: managing diabetes in a 'flash' randomised controlled trial protocol.
    Boucher SE; Gray AR; de Bock M; Wiltshire EJ; Galland BC; Tomlinson PA; Rayns J; MacKenzie KE; Wheeler BJ
    BMC Endocr Disord; 2019 May; 19(1):50. PubMed ID: 31109342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Random blood glucose may be used to assess long-term glycaemic control among patients with type 2 diabetes mellitus in a rural African clinical setting.
    Rasmussen JB; Nordin LS; Rasmussen NS; Thomsen JA; Street LA; Bygbjerg IC; Christensen DL
    Trop Med Int Health; 2014 Dec; 19(12):1515-9. PubMed ID: 25294180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mean HbA
    Forbes A; Murrells T; Mulnier H; Sinclair AJ
    Lancet Diabetes Endocrinol; 2018 Jun; 6(6):476-486. PubMed ID: 29674135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study.
    Bowman P; Sulen Å; Barbetti F; Beltrand J; Svalastoga P; Codner E; Tessmann EH; Juliusson PB; Skrivarhaug T; Pearson ER; Flanagan SE; Babiker T; Thomas NJ; Shepherd MH; Ellard S; Klimes I; Szopa M; Polak M; Iafusco D; Hattersley AT; Njølstad PR;
    Lancet Diabetes Endocrinol; 2018 Aug; 6(8):637-646. PubMed ID: 29880308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Australasian Diabetes Data Network: first national audit of children and adolescents with type 1 diabetes.
    Phelan H; Clapin H; Bruns L; Cameron FJ; Cotterill AM; Couper JJ; Davis EA; Donaghue KC; Jefferies CA; King BR; Sinnott RO; Tham EB; Wales JK; Jones TW; Craig ME
    Med J Aust; 2017 Feb; 206(3):121-125. PubMed ID: 28208043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Individual and diabetes presentation characteristics associated with partial remission status in children and adults evaluated up to 12 months following diagnosis of type 1 diabetes: An ADDRESS-2 (After Diagnosis Diabetes Research Support System-2) study analysis.
    Humphreys A; Bravis V; Kaur A; Walkey HC; Godsland IF; Misra S; Johnston DG; Oliver NS
    Diabetes Res Clin Pract; 2019 Sep; 155():107789. PubMed ID: 31326456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinically meaningful and lasting HbA
    Nirantharakumar K; Mohammed N; Toulis KA; Thomas GN; Narendran P
    Diabetologia; 2018 May; 61(5):1064-1070. PubMed ID: 29478098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT.
    Blair J; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes D; Gamble C
    Health Technol Assess; 2018 Aug; 22(42):1-112. PubMed ID: 30109847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of Hemoglobin A1c before and after initiation of continuous glucose monitoring in children with type 1 diabetes mellitus.
    Gurnurkar S; Owens L; Chalise S; Vyas N
    J Pediatr Endocrinol Metab; 2021 Mar; 34(3):311-317. PubMed ID: 33618445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heterogeneity in glycaemic control in children and adolescents with type 1 diabetes: A latent class trajectory analysis of Danish nationwide data.
    Wibaek R; Ibfelt EH; Andersen GS; Hulman A; Dabelea D; Jørgensen ME; Svensson J; Vistisen D; Rønn PF
    Diabet Med; 2024 Mar; 41(3):e15275. PubMed ID: 38157300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paediatric estimated average glucose in children with Type 1 diabetes.
    O'Riordan SM; Danne T; Hanas R; Peters CJ; Hindmarsh P
    Diabet Med; 2014 Jan; 31(1):36-9. PubMed ID: 23869869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Family conflict, adherence, and glycaemic control in youth with short duration Type 1 diabetes.
    Anderson BJ; Vangsness L; Connell A; Butler D; Goebel-Fabbri A; Laffel LM
    Diabet Med; 2002 Aug; 19(8):635-42. PubMed ID: 12147143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum concentrations of fatty acid-binding protein 4 in Chinese children with type 1 diabetes mellitus.
    Liu H; Guo M; Jiang FL
    J Diabetes Complications; 2018 May; 32(5):488-491. PubMed ID: 29526626
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of intermittently scanned continuous glucose monitoring in young people with high-risk type 1 diabetes-Extension phase outcomes following a 6-month randomized control trial.
    Rose S; Styles SE; Wiltshire EJ; Stanley J; Galland BC; de Bock MI; Tomlinson PA; Rayns JA; MacKenzie KE; Wheeler BJ
    Diabet Med; 2022 May; 39(5):e14756. PubMed ID: 34862661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Poor glycaemic control is associated with increased risk of neurodevelopmental disorders in childhood-onset type 1 diabetes: a population-based cohort study.
    Liu S; Kuja-Halkola R; Larsson H; Lichtenstein P; Ludvigsson JF; Svensson AM; Gudbjörnsdottir S; Tideman M; Serlachius E; Butwicka A
    Diabetologia; 2021 Apr; 64(4):767-777. PubMed ID: 33454829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sociodemographic factors affecting glycaemic control in Finnish paediatric patients with type 1 diabetes.
    Pironetti R; Saha MT; Luukkaala T; Keskinen P
    Endocrinol Diabetes Metab; 2023 Nov; 6(6):e452. PubMed ID: 37749959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of changing insulin dose requirements and glycaemic control in children, adolescents and young adults with Type 1 diabetes.
    Teló GH; Dougher CE; Volkening LK; Katz ML; Laffel LM
    Diabet Med; 2018 Oct; 35(10):1355-1363. PubMed ID: 29855077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diabetes care provision and glycaemic control in Northern Ireland: a UK regional audit.
    Cardwell CR; Patterson CC; Allen M; Carson DJ;
    Arch Dis Child; 2005 May; 90(5):468-73. PubMed ID: 15851427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.